In the TCGA dataset of 407 GC patients, CCL2 mRNA expression was significantly correlated with PDPN (r = 0.504, p < 0.001) and CD31 (r = 0.515, p < 0.001) expression (Figure S2I). Here, CCL2 is linked to gastric cancer.